Jon Gowshall to speak on panel discussion on patenting therapeutic antibodies
Posted:
Partner Jon Gowshall is taking part in a panel discussion about Patent Strategy for Therapeutic Antibodies in the Aftermath of Amgen v. Sanofi. The online seminar will take place on 8 March at 18:00 (UK time).
Jon will present on applicable case law and current examination guidelines for examination of antibody applications in Europe, while the other panellists Mark Lemley, Kevin Kabler and Terri Shieh-Newton will focus on US-specific examination guidelines. The panel will then discuss claim strategy and sufficiency of disclosure, offering some guidance on patent strategy in light of Amgen v. Sanofi, Juno v. Kite, and other relevant cases.
Forresters is delighted to be part of this panel, which is being held as a fundraiser to support the participation of the session’s moderator, David Hoffman, in the 2022 Climb to Fight Cancer on behalf of Fred Hutchinson Cancer Research Center in Seattle, Washington.
To register, please visit: https://secure.fredhutch.org/site/Calendar?id=105283&view=Detail
All participant registration fees will go directly to Fred Hutch in supporting its cutting-edge research mission.
